These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 28316998)

  • 21. Cytokines and persistent viral infections.
    Beltra JC; Decaluwe H
    Cytokine; 2016 Jun; 82():4-15. PubMed ID: 26907634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral Evasion of Natural Killer Cell Activation.
    Ma Y; Li X; Kuang E
    Viruses; 2016 Apr; 8(4):95. PubMed ID: 27077876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of viruses and the humoral innate immune response.
    Maloney BE; Perera KD; Saunders DRD; Shadipeni N; Fleming SD
    Clin Immunol; 2020 Mar; 212():108351. PubMed ID: 32028020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections.
    Hilleman MR
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14560-6. PubMed ID: 15297608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral manipulation of the host immune response.
    Christiaansen A; Varga SM; Spencer JV
    Curr Opin Immunol; 2015 Oct; 36():54-60. PubMed ID: 26177523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response.
    Mingomataj EÇ; Bakiri AH
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):97-113. PubMed ID: 26450621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage.
    O'Garra A; Vieira PL; Vieira P; Goldfeld AE
    J Clin Invest; 2004 Nov; 114(10):1372-8. PubMed ID: 15545984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Viruses as complicating factors during immune reactions].
    Orzechowska B
    Postepy Hig Med Dosw; 1999; 53(4):561-82. PubMed ID: 10544659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viruses as nonspecific modulators of immunological reactivity.
    Semenov BF
    Acta Virol; 1981 Mar; 25(2):122-8. PubMed ID: 6113751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.
    Pellegrini M; Calzascia T; Toe JG; Preston SP; Lin AE; Elford AR; Shahinian A; Lang PA; Lang KS; Morre M; Assouline B; Lahl K; Sparwasser T; Tedder TF; Paik JH; DePinho RA; Basta S; Ohashi PS; Mak TW
    Cell; 2011 Feb; 144(4):601-13. PubMed ID: 21295337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV modulation of host immune responses.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J
    SADJ; 2010 Jul; 65(6):266-8. PubMed ID: 20879650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Virus Infection in Deregulating the Cytokine Response to Secondary Bacterial Infection.
    Mehta D; Petes C; Gee K; Basta S
    J Interferon Cytokine Res; 2015 Dec; 35(12):925-34. PubMed ID: 26308503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-Regulatory Cells as Part of Strategy of Immune Evasion by Pathogens.
    Garib FY; Rizopulu AP
    Biochemistry (Mosc); 2015 Aug; 80(8):957-71. PubMed ID: 26547064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functions of IL-15 in anti-viral immunity: multiplicity and variety.
    Verbist KC; Klonowski KD
    Cytokine; 2012 Sep; 59(3):467-78. PubMed ID: 22704694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expanding realm of heterologous immunity: friend or foe?
    Page KR; Scott AL; Manabe YC
    Cell Microbiol; 2006 Feb; 8(2):185-96. PubMed ID: 16441430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressive functions of B cells in infectious diseases.
    Shen P; Fillatreau S
    Int Immunol; 2015 Oct; 27(10):513-9. PubMed ID: 26066008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis.
    Duell BL; Tan CK; Carey AJ; Wu F; Cripps AW; Ulett GC
    FEMS Immunol Med Microbiol; 2012 Apr; 64(3):295-313. PubMed ID: 22268692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.
    Brito-Melo GE; Peruhype-Magalhães V; Teixeira-Carvalho A; Barbosa-Stancioli EF; Carneiro-Proietti AB; Catalan-Soares B; Ribas JG; ; Martins-Filho OA
    Clin Exp Immunol; 2007 Jan; 147(1):35-44. PubMed ID: 17177961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunomodulation during viral infections].
    Bojić I; Mijusković P; Dujić A
    Med Pregl; 1990; 43(9-10):416-20. PubMed ID: 2077381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breach of IL-12 monopoly in the initiation of type 1 immunity to intracellular infections: IL-12 is not required.
    Xing Z
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):689-94. PubMed ID: 11502076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.